DE69503120D1 - Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen - Google Patents
Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungenInfo
- Publication number
- DE69503120D1 DE69503120D1 DE69503120T DE69503120T DE69503120D1 DE 69503120 D1 DE69503120 D1 DE 69503120D1 DE 69503120 T DE69503120 T DE 69503120T DE 69503120 T DE69503120 T DE 69503120T DE 69503120 D1 DE69503120 D1 DE 69503120D1
- Authority
- DE
- Germany
- Prior art keywords
- anticoagulant
- thrombolytically
- compositions
- thrombolytically active
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003146 anticoagulant agent Substances 0.000 title abstract 6
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 2
- 229960002897 heparin Drugs 0.000 abstract 2
- 229920000669 heparin Polymers 0.000 abstract 2
- 238000009512 pharmaceutical packaging Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 230000002537 thrombolytic effect Effects 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/217,618 US5510330A (en) | 1994-03-25 | 1994-03-25 | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
PCT/EP1995/001061 WO1995026202A1 (en) | 1994-03-25 | 1995-03-22 | Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69503120D1 true DE69503120D1 (de) | 1998-07-30 |
DE69503120T2 DE69503120T2 (de) | 1998-11-12 |
DE69503120T3 DE69503120T3 (de) | 2003-08-14 |
Family
ID=22811809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69503120T Expired - Lifetime DE69503120T3 (de) | 1994-03-25 | 1995-03-22 | Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen |
Country Status (21)
Country | Link |
---|---|
US (1) | US5510330A (de) |
EP (2) | EP0850648A3 (de) |
JP (1) | JPH09510439A (de) |
KR (1) | KR100366982B1 (de) |
CN (1) | CN1090029C (de) |
AT (1) | ATE167631T1 (de) |
AU (1) | AU702470B2 (de) |
BR (1) | BR9507189A (de) |
CA (1) | CA2186390A1 (de) |
CZ (1) | CZ279596A3 (de) |
DE (1) | DE69503120T3 (de) |
DK (1) | DK0751785T4 (de) |
ES (1) | ES2119411T5 (de) |
FI (1) | FI120182B (de) |
MX (1) | MX9603925A (de) |
NO (1) | NO316584B1 (de) |
NZ (1) | NZ282417A (de) |
PL (1) | PL182165B1 (de) |
RU (1) | RU2166326C2 (de) |
UA (1) | UA41398C2 (de) |
WO (1) | WO1995026202A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867275B2 (en) * | 1995-06-07 | 2011-01-11 | Cook Incorporated | Coated implantable medical device method |
US7846202B2 (en) | 1995-06-07 | 2010-12-07 | Cook Incorporated | Coated implantable medical device |
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US7896914B2 (en) * | 1995-06-07 | 2011-03-01 | Cook Incorporated | Coated implantable medical device |
US7550005B2 (en) | 1995-06-07 | 2009-06-23 | Cook Incorporated | Coated implantable medical device |
US20070203520A1 (en) * | 1995-06-07 | 2007-08-30 | Dennis Griffin | Endovascular filter |
US6774278B1 (en) * | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
US6750201B1 (en) * | 1997-10-17 | 2004-06-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
US6517814B2 (en) | 2001-01-09 | 2003-02-11 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants useful for metallopharmaceuticals |
DE10115740A1 (de) * | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
FI20020197A0 (fi) * | 2002-02-01 | 2002-02-01 | Orion Corp | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
US7084118B2 (en) * | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
EP1521603B1 (de) | 2002-07-12 | 2011-01-19 | Cook Incorporated | Beschichtete medizinische vorrichtung |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
AU2005248772B2 (en) * | 2004-05-17 | 2010-11-25 | Medtronic, Inc. | Point of care heparin determination system |
US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
TWI482628B (zh) * | 2007-10-18 | 2015-05-01 | Lundbeck & Co As H | 新穎之血栓溶解病患次群 |
WO2009080054A1 (en) * | 2007-12-21 | 2009-07-02 | Ifxa A/S | Protease inhibitor |
EP3215221B1 (de) | 2014-11-03 | 2020-02-26 | Thrombolytic Science, LLC | Verfahren und zusammensetzungen zur sicheren und wirksamen thrombolyse |
WO2016122288A2 (ko) * | 2015-01-30 | 2016-08-04 | 고려대학교산학협력단 | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 |
RU2622006C2 (ru) * | 2015-06-15 | 2017-06-08 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) | Применение рекомбинантного штамма bacillus subtilis eo-11 вкпм в-11978 в качестве продуцента субтилизиноподобной протеиназы, вещества с тромболитическими и антикоагулянтными свойствами |
CN105396127A (zh) * | 2015-11-13 | 2016-03-16 | 中国人民解放军第四军医大学 | 一种用于急性心肌梗死的冠状动脉溶栓剂 |
US11154596B2 (en) | 2017-06-16 | 2021-10-26 | Thrombolytic Science, Llc | Methods for thrombolysis |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8508717D0 (en) * | 1985-04-03 | 1985-05-09 | Beecham Group Plc | Composition |
DK43387A (da) † | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
US5084274A (en) * | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
DE3804600A1 (de) * | 1988-02-13 | 1989-08-24 | Basf Ag | Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz |
GB8822147D0 (en) * | 1988-09-21 | 1988-10-26 | Ciba Geigy Ag | Pharmaceutically active combination |
US5204323B1 (en) * | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
GB8826428D0 (en) * | 1988-11-11 | 1988-12-14 | Biopharm Ltd | Antithrombin |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
DE3903581A1 (de) * | 1989-02-07 | 1990-08-16 | Boehringer Mannheim Gmbh | Gewebs-plasminogenaktivator-derivat |
CA2064231A1 (en) * | 1989-07-20 | 1991-01-21 | John M. Maraganore | Combinations and methods for treating or preventing thrombotic diseases |
US5240913A (en) * | 1989-08-18 | 1993-08-31 | Biogen, Inc. | Inhibitors of thrombin |
US5196404B1 (en) * | 1989-08-18 | 1996-09-10 | Biogen Inc | Inhibitors of thrombin |
US5049132A (en) * | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
US5189019A (en) * | 1990-04-23 | 1993-02-23 | Merck & Co., Inc. | Antistasin derived anticoagulant protein |
US5242810A (en) * | 1990-12-07 | 1993-09-07 | Biogen, Inc. | Bifunctional inhibitors of thrombin and platelet activation |
US5242688A (en) * | 1990-12-24 | 1993-09-07 | Eli Lilly And Company | Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
DK0580685T3 (da) † | 1991-04-16 | 1996-03-04 | Boehringer Mannheim Gmbh | Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift |
JP3559559B2 (ja) † | 1992-06-03 | 2004-09-02 | ジェネンテク,インコーポレイテッド | 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体 |
-
1994
- 1994-03-25 US US08/217,618 patent/US5510330A/en not_active Expired - Lifetime
-
1995
- 1995-03-22 EP EP98102473A patent/EP0850648A3/de not_active Ceased
- 1995-03-22 DE DE69503120T patent/DE69503120T3/de not_active Expired - Lifetime
- 1995-03-22 BR BR9507189A patent/BR9507189A/pt not_active Application Discontinuation
- 1995-03-22 MX MX9603925A patent/MX9603925A/es not_active IP Right Cessation
- 1995-03-22 UA UA96104031A patent/UA41398C2/uk unknown
- 1995-03-22 PL PL95316449A patent/PL182165B1/pl not_active IP Right Cessation
- 1995-03-22 DK DK95912261T patent/DK0751785T4/da active
- 1995-03-22 CZ CZ962795A patent/CZ279596A3/cs unknown
- 1995-03-22 CA CA002186390A patent/CA2186390A1/en not_active Abandoned
- 1995-03-22 ES ES95912261T patent/ES2119411T5/es not_active Expired - Lifetime
- 1995-03-22 AU AU19511/95A patent/AU702470B2/en not_active Ceased
- 1995-03-22 KR KR1019960705381A patent/KR100366982B1/ko not_active IP Right Cessation
- 1995-03-22 AT AT95912261T patent/ATE167631T1/de active
- 1995-03-22 NZ NZ282417A patent/NZ282417A/en not_active IP Right Cessation
- 1995-03-22 RU RU96119944/14A patent/RU2166326C2/ru not_active IP Right Cessation
- 1995-03-22 EP EP95912261A patent/EP0751785B2/de not_active Expired - Lifetime
- 1995-03-22 CN CN95192275A patent/CN1090029C/zh not_active Expired - Fee Related
- 1995-03-22 JP JP7519775A patent/JPH09510439A/ja active Pending
- 1995-03-22 WO PCT/EP1995/001061 patent/WO1995026202A1/en not_active Application Discontinuation
-
1996
- 1996-09-24 FI FI963802A patent/FI120182B/fi not_active IP Right Cessation
- 1996-09-24 NO NO19964007A patent/NO316584B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69503120D1 (de) | Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen | |
PT740650E (pt) | Co-farmacos como um metodo de administracao controlada de farmacos | |
DE69123795T3 (de) | Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau | |
DE69226369D1 (de) | System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln | |
ES2168302T3 (es) | Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e. | |
CY1113355T1 (el) | Χρηση θεραπειας νευροτοξινης για θεραπευτικη αγωγη ουρολογικων και σχετικων διαταραχων | |
DK1393750T3 (da) | Antistoffer til behandling af en immunsygdom | |
DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
FI972308A (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
DE69521693T2 (de) | Taxanderivate enthaltende arzneizubereitungen | |
DE69322251D1 (de) | Medizinische zusammensetzung | |
ATE165514T1 (de) | Verwendung von inosittriphosphat zur zubereitung von medikamenten | |
DE69821498D1 (de) | Verwendung von amifostin | |
ATE272405T1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
RS52011B (sr) | Nova primena derivata taksoida | |
ATE38151T1 (de) | Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung. | |
ES2175006T3 (es) | N-(pirimidinil)-benzosulfonamidas como medicamentos. | |
DE69700983D1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
DE69326627T2 (de) | Therapeutisches Mittel gegen drohenden Abortus | |
NO304518B1 (no) | Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem | |
DE69902925T2 (de) | Ramoplaninhaltige neue injizierbare arzneizubereitungen | |
DE69009765T2 (de) | Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69008282D1 (de) | Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen. | |
ES2101982T3 (es) | Composicion conteniendo una alta dosis de vitamina a. | |
ITMI922040A1 (it) | Composizioni farmaceutiche per il trattamento di stati di iperaggregabilita' piastrinica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE |
|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ACTAVIS GROUP PTC EHF., HAFNARFJORDUR, IS |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: WEICKMANN & WEICKMANN, 81679 MUENCHEN |